CL2022003741A1 - Agente anticoccidio y método para su uso - Google Patents

Agente anticoccidio y método para su uso

Info

Publication number
CL2022003741A1
CL2022003741A1 CL2022003741A CL2022003741A CL2022003741A1 CL 2022003741 A1 CL2022003741 A1 CL 2022003741A1 CL 2022003741 A CL2022003741 A CL 2022003741A CL 2022003741 A CL2022003741 A CL 2022003741A CL 2022003741 A1 CL2022003741 A1 CL 2022003741A1
Authority
CL
Chile
Prior art keywords
anticoccidial
agent
anticoccidial agent
general formula
halogen
Prior art date
Application number
CL2022003741A
Other languages
English (en)
Spanish (es)
Inventor
Fujihara Hirokazu
Fuchi Shunsuke
Abe Yutaka
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of CL2022003741A1 publication Critical patent/CL2022003741A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles
    • A01N43/521,3-Diazoles; Hydrogenated 1,3-diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/02Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Insects & Arthropods (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Toxicology (AREA)
CL2022003741A 2020-07-03 2022-12-23 Agente anticoccidio y método para su uso CL2022003741A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020115725 2020-07-03
JP2020151716 2020-09-10

Publications (1)

Publication Number Publication Date
CL2022003741A1 true CL2022003741A1 (es) 2023-09-15

Family

ID=79316465

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2022003741A CL2022003741A1 (es) 2020-07-03 2022-12-23 Agente anticoccidio y método para su uso

Country Status (15)

Country Link
US (2) US12521381B2 (https=)
EP (1) EP4176717A4 (https=)
JP (1) JP7514930B2 (https=)
KR (1) KR102906933B1 (https=)
CN (1) CN115768426B (https=)
AU (1) AU2021299350B2 (https=)
BR (1) BR112022026544A2 (https=)
CA (1) CA3187867A1 (https=)
CL (1) CL2022003741A1 (https=)
CO (1) CO2023001236A2 (https=)
MX (1) MX2022016546A (https=)
MY (1) MY206330A (https=)
UA (1) UA129752C2 (https=)
WO (1) WO2022004877A1 (https=)
ZA (1) ZA202212291B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022255460A1 (ja) * 2021-06-02 2022-12-08 日本農薬株式会社 ベンゾイミダゾール化合物又はその塩類及び該化合物を含有する犬糸状虫症防除剤並びにその使用方法
CN117396467A (zh) * 2021-06-02 2024-01-12 日本农药株式会社 苯并咪唑化合物或其盐类和包含该化合物的犬心丝虫病防治剂及其使用方法
CN120187723A (zh) * 2023-09-26 2025-06-20 山东康乔生物科技有限公司 芳杂环类化合物和/或其盐及其制备方法与应用和杀虫杀螨剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3271249A (en) 1963-06-24 1966-09-06 S B Penick & Co Inc Dihalobenzimidazoles for poultry disease treatment
US5331003A (en) * 1993-03-26 1994-07-19 Eli Lilly And Company Anticoccidial methods
CA2222517C (en) * 1995-05-31 2006-10-24 Bayer Aktiengesellschaft Agents for use against parasitic protozoa
DE19519821A1 (de) * 1995-05-31 1996-12-05 Bayer Ag Mittel gegen parasitäre Protozoen
DE19920551A1 (de) * 1999-05-05 2000-11-09 Bayer Ag Substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen
JP2004051510A (ja) 2002-07-17 2004-02-19 Kawasaki Kasei Chem Ltd 坑コクシジウム剤
ZA200602181B (en) * 2003-09-22 2007-06-27 S Bio Pte Ltd Benzimidazole derivatives: Preparation and pharmaceutical applications
WO2005028447A1 (en) * 2003-09-22 2005-03-31 S*Bio Pte Ltd Benzimidazole derivates: preparation and pharmaceutical applications
CA2682676A1 (en) 2007-04-19 2008-10-30 Novartis Ag Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5
JP5514716B2 (ja) * 2007-05-11 2014-06-04 コリア・リサーチ・インスティテュート・オブ・ケミカル・テクノロジー アリールピペリジン置換基を有するイミダゾール誘導体、その製造方法及びこれを含む医薬組成物
WO2009051705A1 (en) * 2007-10-18 2009-04-23 Merck & Co., Inc. Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
US8969342B2 (en) * 2009-03-20 2015-03-03 Brandeis University Compounds and methods for treating mammalian gastrointestinal microbial infections
US8689541B2 (en) 2011-02-16 2014-04-08 GM Global Technology Operations LLC Valvetrain control method and apparatus for conserving combustion heat
WO2017132511A1 (en) * 2016-01-27 2017-08-03 Southern Research Institute Benzimidazole compounds, use as inhibitors of wnt signaling pathway in cancers, and methods for preparation thereof
UY37866A (es) * 2017-09-07 2019-03-29 Glaxosmithkline Ip Dev Ltd Nuevos compuestos derivados de benzoimidazol sustituidos que reducen la proteína myc (c-myc) en las células e inhiben la histona acetiltransferasa de p300/cbp.
EP3798212A4 (en) 2018-05-22 2022-03-23 Nihon Nohyaku Co., Ltd. BENZIMIDAZOLE COMPOUND OR SALT THEREOF, INSECTICIDE AND ACARICIDE FOR AGRICULTURE AND HORTICULTURE WITH THIS COMPOUND AND METHODS OF USE
WO2022255460A1 (ja) * 2021-06-02 2022-12-08 日本農薬株式会社 ベンゾイミダゾール化合物又はその塩類及び該化合物を含有する犬糸状虫症防除剤並びにその使用方法

Also Published As

Publication number Publication date
US20230338350A1 (en) 2023-10-26
CN115768426A (zh) 2023-03-07
KR102906933B1 (ko) 2026-01-05
EP4176717A1 (en) 2023-05-10
MY206330A (en) 2024-12-11
AU2021299350B2 (en) 2024-12-05
AU2021299350A1 (en) 2023-02-23
KR20230029854A (ko) 2023-03-03
WO2022004877A1 (ja) 2022-01-06
JPWO2022004877A1 (https=) 2022-01-06
EP4176717A4 (en) 2024-09-11
CN115768426B (zh) 2025-03-07
BR112022026544A2 (pt) 2023-01-17
JP7514930B2 (ja) 2024-07-11
UA129752C2 (uk) 2025-07-23
CA3187867A1 (en) 2022-01-06
US20260014131A1 (en) 2026-01-15
ZA202212291B (en) 2024-04-24
CO2023001236A2 (es) 2023-02-16
US12521381B2 (en) 2026-01-13
MX2022016546A (es) 2023-02-01

Similar Documents

Publication Publication Date Title
CL2022003741A1 (es) Agente anticoccidio y método para su uso
ECSP20044709A (es) Inhibidores de sarcómero cardíaco
PE20221339A1 (es) Inhibidores de parp1
ECSP21016009A (es) Inhibidores de sarcómeros cardíacos
CL2022001529A1 (es) Nuevos derivados de metilquinazolinona
CO2026002343A2 (es) Inhibidores de pi3k
PE20020786A1 (es) Derivados de azaindol antiviral
CL2020002579A1 (es) Compuesto de fenoxiurea y un agente de control de plagas.
MX2019009384A (es) Composiciones generadoras de gastrotransmisores electroquimicos y sus metodos de uso y apositos y sistemas de tratamiento que los incorporan.
AR129265A1 (es) Compuestos de alcoxi-heteroaril-carboxamida o tioamida
MX2022012061A (es) Metodo de control de plagas, composicion del agente de control de plagas y conjunto de agentes de control de plagas.
CO2025005865A2 (es) Compuesto heterocíclico
CL2023001440A1 (es) Nuevos derivados de indazol acetileno
CL2023000313A1 (es) Forma sólida de un compuesto
MX2024012884A (es) Compuestos de liberacion de gamma-hidroxibutirato y procesos para fabricar y usar los mismos
AR122865A1 (es) Agente anticoccidio y método para su uso
CO2025004117A2 (es) Compuesto de ariltetrahidropiridina y agente de con-trol de plagas
PE20191788A1 (es) Compuesto de n-(4-piridil)nicotinamida o sal del mismo
AR126996A1 (es) Compuestos de isoxazolina y su uso como agentes de control de plagas
CO2023017613A2 (es) Compuesto de bencimidazol o sal del mismo, agente de control de la filariasis canina que lo contiene y método de uso del mismo
CR20230437A (es) Nuevos derivados de tiazolopirimidinona
AR133276A1 (es) Nuevos derivados de pirazolopiridina
PE20201148A1 (es) Compuestos biciclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias
PY2160800A (es) Una mezcla pesticidamente activa que comprende el compuesto de pirazolopiridina antranilamida, sus oxidos o sales de los mismos
CL2021002373A1 (es) Fármaco y método para tratar o prevenir las complicaciones de la diabetes utilizando dicho fármaco